Medicines Optimisation
Maximising Quality Prescribing.
MMS Medicines Optimisation Programmes.
MMS have a range of medicines optimisation services designed to reduce inappropriate prescribing, ensuring patient safety supporting the Integrating Pharmacy and Medicines Optimisation (IPMO) programme whilst reducing budgetary savings in line with the national QIPP challenges.
Our range of therapy optimisation programmes can be delivered with flexible models in both delivery and funding. These include part or full sponsorship, in which case clinical reviews may be implemented with no cost implications to your healthcare organisation.
Alternatively, an invest to save model would typically deliver in excess of a five-fold return on investment.
On average our suite of optimisation programmes generate a deliverable saving projection of £500,000 per 100,000 population.
QIPP Initiatives
MMS have designed over 20 programmes to support NHS QIPP and medicines optimisation priorities across a broad range of therapy areas and conditions, including; respiratory, malnutrition, osteoporosis, dermatology, inflammatory bowel disease, diabetes, stroke prevention and other cardiovascular conditions.
Key features & benefits include;
Optimise therapeutic management of patients
Promote alignment to national and local guidance
Maximise opportunities to reduce cost and medicines waste
Reduce medicines related adverse effects and admissions
Commissioning for Quality.
MMS® can develop GP Pharmacist Services to manage patient centred clinical review projects to improve patient health outcomes in line with CCG objectives and NHS Right Care strategies.
MMS® have experience in delivering in the following areas:
Care Home Reviews
Stroke Prevention
Domiciliary and Frailty Reviews
Reducing risk of hospital admission / Virtual Clinics
Embedding GP Practice Pharmacists
Improving Health Outcomes through GP Pharmacist Services
Contact us.
Contact us to find out more about our Medicines Optimisation Programmes or for a bespoke model that suits your requirements.